# Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment

> **NCT02002767** · PHASE1 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 19 (actual)

## Conditions studied

- Hepatitis C Virus

## Interventions

- **DRUG:** Velpatasvir

## Key facts

- **NCT ID:** NCT02002767
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-16
- **Primary completion:** 2014-06-09
- **Final completion:** 2014-06-09
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002767, "Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02002767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*